- 29 Oct 2024
- ICICI Securities
HESTER BIOSCIENCES Q2FY25- STRONG GROWTH IN ANIMAL HEALTHCARE
News: Revenues grew ~19% YoY to ₹ 83.7 crore driven mainly by Animal Healthcare. EBITDA grew ~45% YoY to ₹ 198 crore with 414 bps margin expansion to 22.9%. Animal Healthcare (50% of sales) grew 27% YoY to ₹ 41.8 crore driven by good demand in the domestic dairy sector and besides growth in feed- supplements and new launches. Exports of vaccines from Hester Nepal and Hester Africa also did well. Poultry Healthcare (49% of sales) grew 11% YoY to ₹ 40.8 crore driven by vaccine exports and new launches in health product segments.
ViewS: Revenues grew ~19% YoY to ₹ 83.7 crore driven mainly by Animal Healthcare. EBITDA grew ~45% YoY to ₹ 198 crore with 414 bps margin expansion to 22.9%. Animal Healthcare (50% of sales) grew 27% YoY to ₹ 41.8 crore driven by good demand in the domestic dairy sector and besides growth in feed- supplements and new launches. Exports of vaccines from Hester Nepal and Hester Africa also did well. Poultry Healthcare (49% of sales) grew 11% YoY to ₹ 40.8 crore driven by vaccine exports and new launches in health product segments.
Impact: Positive